CAS No. |
4929-23-1 |
|---|---|
中文名称 |
9-氯-5-丙基-5,11-二氢-6H-苯并[e]吡啶并[3,2-b][1,4]二氮杂䓬-6-酮 |
英文名称 |
9-chloro-5-propyl-5,11-dihydro-6H-benzo[e]pyrido[3,2-b][1,4]diazepin-6-one |
别名 |
6H-Pyrido[2,3-b][1,4]benzodiazepin-6-one, 9-chloro-5,11-dihydro-5-propyl-;9-Chloro-5,11-dihydro-5-propyl-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one;BI-0115;inhibit,BI-0115,LOX-1,atherosclerosis,BI0115,BI 0115,oxLDL binding,Inhibitor;14-chloro-9-propyl-2,4,9-triazatricyclo[9.4.0.03,?]pentadeca-1(11),3(8),4,6,12,14-hexaen-10-one;9-Chloro-5-propyl-5,11-dihydro-6H-benzo[e]pyrido[3,2-b][1,4]diazepin-6-one |
标准英文名 |
9-chloro-5-propyl-5,11-dihydro-6H-benzo[e]pyrido[3,2-b][1,4]diazepin-6-one |
分子式 |
C15H14ClN3O |
分子量 |
287.75 |
精确分子量 |
287.08 |
SMILES |
CCCN1C(=O)C2=C(C=C(Cl)C=C2)NC2=C1C=CC=N2 |
标准SMILES |
CCCN1C(=O)C2C=CC(Cl)=CC=2NC2N=CC=CC1=2 |
用途 |
BI-0115 is a selective LOX-1 inhibitor (IC50 = 5.4 µM) that blocks cellular uptake of oxidized low-density lipoprotein (oxLDL); it inhibits the receptor by binding to and stabilizing the dimeric form of the ligand-binding domain. |
InChIKey |
QTCZUCSALXBZQR-UHFFFAOYSA-N |
|
|
评论 |
|---|